Inactief instrument

Koers Kythera Biopharmaceuticals Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Kythera Biopharmaceuticals : Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin	08-10-15
Kythera Biopharmaceuticals : ® Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	08-10-15
Allergan : forecasts second-half revenue above $8 billion	28-09-15
KYTHERA(R) Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	22-09-15
KYTHERA(R) Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat	18-08-15

Managers	Titel	Leeftijd	Van
Ambrose Bailey PSD	President	60	01-10-15
Maria Hilado BRD	Director/Board Member	59	01-10-15
Jere D. Fellmann PRN	Corporate Officer/Principal	72	01-06-12

Besturend	Titel	Leeftijd	Van
Maria Hilado BRD	Director/Board Member	59	01-10-15
Ambrose Bailey PSD	President	60	01-10-15
Steven Fagien BRD	Director/Board Member	-	-

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-3,30%	102 mld.
REGENERON PHARMACEUTICALS, INC.	+1,79%	96,07 mld.
ARGENX SE	-1,75%	21,66 mld.
BIONTECH SE	-18,35%	20,77 mld.
GENMAB A/S	-7,45%	18,53 mld.
WUXI APPTEC CO., LTD.	-40,31%	16,91 mld.
BEIGENE, LTD.	-26,84%	13,79 mld.
NEUROCRINE BIOSCIENCES, INC.	+0,59%	13,33 mld.
SAREPTA THERAPEUTICS, INC.	+20,86%	10,94 mld.